IP Library Granted Patent US 7,917,227
Granted Patent B2
US 7,917,227 · App. 11/537,026 · Granted Mar 29, 2011

Optimizing characteristics of an electric field to increase the field's effect on proliferating cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,917,227
App. No.
11/537,026
Granted
Mar 29, 2011
Kind
B2
Abstract

AC electric fields at particular frequencies and field strengths have been shown to be effective for destroying rapidly proliferating cells such as cancer cells. The effectiveness of such fields is improved when the field is sequentially switched between two or more different directions. The effectiveness of such fields can be improved even further by choosing the rate at which the field is switched between the various directions.

Claims (30)

1. A method of treating a tumor comprising the step of:

applying an electric field with a frequency between 50 and 500 kHz and a field strength of at least 1 V/cm to the tumor,

cyclically changing the direction of the electric field between a first direction and a second direction, with the field applied for between 20 and 500 ms in the first direction and for between 20 and 500 ms in the second direction during each cycle.

2. The method of claim 1 , wherein the field is applied for between 50 and 250 ms in the first direction and for between 50 and 250 ms in the second direction during each cycle.

3. The method of claim 2 , wherein the field is applied for the same amount of time in the first direction as in the second direction during each cycle.

4. The method of claim 2 , wherein the first direction is substantially normal to the second direction.

5. The method of claim 2 , wherein the electric field has a frequency between 100 and 200 kHz.

6. The method of claim 5 , wherein the field is applied for the same amount of time in the first direction as in the second direction during each cycle.

7. A method of treating a tumor comprising the steps of:

(a) applying a first electric field to the tumor in a first direction for a first period of time, wherein the first electric field has a frequency and field strength that damages dividing cells but leaves nondividing cells substantially unharmed, and wherein the first period of time is selected to increase the efficacy of the treatment;

(b) applying a second electric field to the tumor in a second direction for a second period of time that is subsequent to the first period of time, wherein the second electric field has a frequency and field strength that damages dividing cells but leaves nondividing cells substantially unharmed, wherein the second period of time is selected to increase the efficacy of the treatment, and wherein the first direction and the second direction are different; and

(c) cyclically repeating steps (a) and (b), wherein the first period of time is between 20 and 500 ms and the second period of time is between 20 and 500 ms.

8. The method of claim 7 , wherein the first period of time is between 50 and 250 ms and the second period of time is between 50 and 250 ms.

9. The method of claim 8 , wherein the first period of time is about equal to the second period of time.

10. The method of claim 7 , wherein the first direction is substantially normal to the second direction.

11. A method of applying a therapeutic electric field to a target region, the method comprising:

generating a periodic control signal with first and second output states, wherein the duration of the first state is between 20 and 500 ms and the duration of the second state is between 20 and 500 ms;

generating a first AC signal when the control signal is in its first state and generating a second AC signal when the control signal is in its second state;

applying the first AC signal across a first pair of insulated electrodes to induce a first electric field in the target region at a first direction, the first electric field having a field strength of at least 1 V/cm and a frequency between 50 and 500 kHz; and

applying the second AC signal across a second pair of insulated electrodes to induce a second electric field in the target region at a second direction, the second electric field having a field strength of at least 1 V/cm and a frequency between 50 and 500 kHz.

12. The method of claim 11 , wherein the duration of the first state is between 50 and 250 ms and the duration of the second state is between 50 and 250 ms.

13. The method of claim 12 , wherein the duration of the first state is about the same as the duration of the second state.

14. The method of claim 12 , wherein the electric field has a frequency between 100 and 200 kHz.

15. The method of claim 12 , wherein the first AC signal and the second AC signal are turned on at a rate that is slow relative to the reciprocal of the field frequency, and fast relative to the half cycle duration.

16. The method of claim 11 , wherein the first AC signal and the second AC signal are turned on at a rate that reaches 90% of the steady-state values between 1-5 ms.

17. A method of treating a tumor comprising the steps of:

(a) applying a first electric field to the tumor in a first direction for a first period of time, wherein the first electric field has a frequency and field strength that damages dividing cells but leaves nondividing cells substantially unharmed, and wherein the first period of time is selected to increase the efficacy of the treatment;

(b) applying a second electric field to the tumor in a second direction for a second period of time that is subsequent to the first period of time, wherein the second electric field has a frequency and field strength that damages dividing cells but leaves nondividing cells substantially unharmed, wherein the second period of time is selected to increase the efficacy of the treatment, and wherein the first direction and the second direction are different; and

(c) cyclically repeating steps (a) and (b), wherein the first electric field and the second electric field are turned on at a rate that is slow relative to the reciprocal of the field frequency, and fast relative to the half cycle duration.

18. The method of claim 17 , wherein the first electric field and the second electric field are turned on at a rate that reaches 90% of the steady-state values between 1-5 ms.

Assignments (19)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
SECURITY AGREEMENT Recorded Feb 20, 2013
From: NOVOCURE LIMITED
To: DEUTSCHE BANK TRUST COMPANY AMERICAS
Reel/Frame 029845/0135 →
CHANGE OF NAME Recorded May 19, 2011
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 026311/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2008
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 020934/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2007
From: FROSIEN, JUERGEN
To: APPLIED MATERIALS, INC.
Reel/Frame 018988/0014 →